While the etiology of IGF‐1 in second primary prostate cancer is unknown, it is plausible that those who develop prostate cancer may possess a common genetic, hormonal, or environmental factor that protects them from developing a SPC 119. This evidence concerns the gene IGF1 and prostate cancer.